I guess we have to agree to disagree on which drug
Post# of 72447
Posted On: 06/07/2016 6:04:02 PM
Re: scottsmith #23656
I guess we have to agree to disagree on which drug is more valuable right now. Stemcentrx's Phase 1 cancer drug was acquired by AbbVie for $5.8B (up to $10.2B). It'll be great if you can show me a Phase 2 psoriasis drug being acquired for a greater amount.
http://www.businessinsider.com/stemcentrx-rov...r%20Select
http://www.businessinsider.com/stemcentrx-rov...r%20Select
Quote:
I was trying to say that P is more valuable than K RIGHT NOW.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
